Back

She s Sleeping Better, but Are We Raising Her Blood Pressure? Debating the Sodium Cost of Oxybates

Although high-level clinical trials have not established a definitive link between additional cardiovascular risks and sodium in oxybates, a broader medical consensus emphasizes the importance of sodium reduction to mitigate cardiovascular morbidity. Here narcolepsy experts Dr Alon Avidan and Dr Phyllis Zee explore the therapeutic trade-offs between formulation-specific attributes, such as sodium content and dosing frequency, and the physiological benefits of restored sleep architecture with oxybates. Clinicians who manage narcolepsy will gain practical strategies for optimizing treatment with oxybates while monitoring for cardiovascular risks.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 0.25 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Enduring / On-demand
  • Credit · Up to 0.25 credits
  • Commercial Support
  • Released
    Apr 17, 2026
  • Last day to claim credit
    Apr 18, 2027 6 months left